Immune Cells & Metastasis Lab
The CRUK Beatson Institute is a cancer research institute, situated in Glasgow with approximately 250 researchers split across 30 research groups consisting of PIs, postdoctoral scientists, PhD students and scientific officers. It is one of Europe's leading cancer research centres, supporting cutting-edge work into the molecular mechanisms of cancer development. As well as core support from Cancer Research UK, the Institute also receives an additional third of its total income from external grants and industry collaborations. It has an excellent reputation for fundamental cancer research, including world-class metabolism studies and renowned in vivo modelling of tumour growth and metastasis. Its research ethos is about excellence, honesty, openness, accountability, and integrity.
The diversity of our staff and students is what makes the CRUK Beatson Institute a great place to work and advance discoveries in cancer research. Family friendly policies, our collaborative ethos, a focus on good mental health and well-being and opportunities for all, help to create an enjoyable and inclusive workplace where your voice matters.
Immune cells play important roles during cancer progression. The Coffelt lab (https://www.beatson.gla.ac.uk/Invasion-and-Metastasis/seth-coffelt-immune-cells-and-metastasis.html)
investigates one rare type of immune cell, called a gamma delta T cell, which can recognize and kill cancer cells. Our lab is interested in understanding how these cells prevent tumour growth in mouse models of colon cancer. We are looking for a senior scientific officer to join the team to work in this area of cancer immunology. The emphasis of this role will be to support other lab members through experimentation and lab management.
You should possess a degree at 2(1) or above in a relevant subject and preferentially a PhD. PhD candidates will be considered for this role. The successful applicant will be ambitious and passionate about research. Previous experience in molecular biology and/or genetically engineered in vivo cancer models would be a significant advantage, however, we can provide the necessary training for excellent candidates with a good understanding of tumour biology. Experience in cell culture, organoids, immunohistochemistry and flow cytometry is also desirable. Experience of in-vivo techniques and possession of a Home Office personal licence would be advantageous but not essential. You should be able to work both independently and in close collaboration with the researchers, and be highly motivated with good communication, project management and organisational skills.
For informal enquiries please email seth.coffelt@glasgow.ac.uk
Closing Date for Applications: 31 October 2022.